About us
The independent Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) examines the benefits and harms of medical interventions for patients.
Projects
Participation
Events
Press
Contact
Breadcrumbs
Last updated 21.02.2008
Project no.: A04-01A
Commission: Commission awarded on 15.12.2004 by the Federal Joint Committee (G-BA).
Report type: Report
Status: Commission completed
Department/Division: Drug Assessment
Topic: Heart and circulation
Final report: Clopidogrel versus acetylsalicylic acid for the secondary prevention of vascular diseases
published on Aug 25, 2006
Preliminary report: Clopidogrel versus acetylsalicylic acid for the secondary prevention of vascular diseases
published on Apr 4, 2006
Report plan version 1.0: Clopidogrel versus acetylsalicylic acid for the secondary prevention of vascular diseases
published on Jul 28, 2005
2008-02-21 A G-BA decision was published.
G-BA documents on this decision (German only)
Press contact
+49 221 356850
presse@iqwig.de
Info Service (German)
Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.
Contact form
Questions about commissions, publications and press releases can be sent to us via this form.
Accompanying information